MedPage Today on MSN
FDA Proposes More Flexibility in Alternatives to Animal Testing in Drug Development
Non-animal testing methods could save drugmakers time and money, officials say ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
FDA’s NAM framework emphasizes context of use, human biological relevance, technical characterization, and fit-for-purpose ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...
March 18 (Reuters) - The U.S. Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
A team of researchers from Drexel University has developed an innovative approach to rigorously test and improve the robustness of autonomous driving systems. Their study, presented this summer at ...
In this and the next four chapters, the panel assesses the industry practices described at the workshop and discusses their applicability within defense acquisitions. As noted in Chapter 1, a number ...
The cannabis market is rapidly growing as legalization continues to increase across the United States and Internationally. As a result, an influx of different types of cannabis infused edibles and ...
In this chapter, we focus on two topics: the lack of enforcement of existing U.S. Department of Defense (DOD) guidelines and procedures and the role of the program manager in the acquisition process.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results